The National Institutes of Health is offering this grant to implement comprehensive HIV services within Syringe Service Programs (SSPs). This grant is for addressing the critical need for sustainable, integrated HIV prevention and care models in the increasing number of SSPs across the U.S. Many newer SSPs, especially in rural areas, lack expertise in HIV services and rely on limited referrals. Despite these challenges, SSPs offer unique opportunities for consistent engagement with people who inject drugs (PWID) and their networks, facilitating better HIV prevention and treatment outcomes. This initiative seeks implementation-focused research to develop effective models, complementing ongoing efforts by the CDC and SAMHSA to strengthen SSP infrastructure and client engagement. The goal is to improve the continuum of HIV prevention and care delivery in these vital settings.
Opportunity ID: 338365
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-23-007 |
| Funding Opportunity Title: | Implementing Comprehensive HIV services in Syringe Service Program (SSP) Settings (R34 – Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 25, 2022 |
| Last Updated Date: | Feb 25, 2022 |
| Original Closing Date for Applications: | Aug 11, 2023 |
| Current Closing Date for Applications: | Aug 11, 2023 |
| Archive Date: | Sep 16, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public and State controlled institutions of higher education State governments Special district governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | There has been a substantial increase in the number of syringe service programs (SSPs) in the US and the range of these settings has become broader, with many now located in health department or FQHCs, in addition to the more traditional CBO and AIDS Service Organization settings. There is a need to provide models for bringing sustainable integrated HIV prevention and care into SSP settings. Newer SSPs often are in settings that have limited expertise for other substance use services and may be limited in terms of HIV care. More established SSPs may provide HIV testing, but often do not directly provide other HIV prevention and care services and rely on referrals with limited follow-up. SSPs provide opportunities for regular contact with PWID and their network members (including non-injectors) which may enable greater engagement and re-engagement across the HIV continua of prevention and treatment. Newer SSPs often are in rural areas with limited capacity to provide a range of HIV services and the COVID pandemic has required restructuring of services and has led to some closures. CDC is developing infrastructure to better monitor SSP programs, survey clients, and develop technical assistance models for SSPs. A program of implementation-focused research to improve HIV prevention and care would complement this effort, as well as SAMHSAs support of these settings. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00272340 | Jul 11, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278301 | Nov 10, 2022 | Aug 11, 2023 | View |
Package 1
Mandatory forms
338365 RR_SF424_5_0-5.0.pdf
338365 PHS398_CoverPageSupplement_5_0-5.0.pdf
338365 RR_OtherProjectInfo_1_4-1.4.pdf
338365 PerformanceSite_4_0-4.0.pdf
338365 RR_KeyPersonExpanded_4_0-4.0.pdf
338365 PHS398_ResearchPlan_4_0-4.0.pdf
338365 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338365 RR_Budget_3_0-3.0.pdf
338365 RR_SubawardBudget30_3_0-3.0.pdf
338365 PHS398_ModularBudget_1_2-1.2.pdf
338365 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
338365 RR_SF424_5_0-5.0.pdf
338365 PHS398_CoverPageSupplement_5_0-5.0.pdf
338365 RR_OtherProjectInfo_1_4-1.4.pdf
338365 PerformanceSite_4_0-4.0.pdf
338365 RR_KeyPersonExpanded_4_0-4.0.pdf
338365 PHS398_ResearchPlan_5_0-5.0.pdf
338365 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
338365 RR_Budget_3_0-3.0.pdf
338365 RR_SubawardBudget30_3_0-3.0.pdf
338365 PHS398_ModularBudget_1_2-1.2.pdf
338365 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
